Abvc biopharma, inc. announces pricing of $6.875 million firm commitment offering

Fremont, ca, aug. 03, 2021 (globe newswire) -- via newmediawire -- abvc biopharma, inc. (abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (cns), and ophthalmology, today announced the pricing of its firm commitment offering of 1,100,000 units at an offering price of $6.25 per unit for total gross proceeds of $6.875 million.
ABVC Ratings Summary
ABVC Quant Ranking